Cellebrite DI Ltd.
CLBT
$17.09
$0.482.89%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 181.79% | 231.56% | 26.39% | -75.77% | |
| Total Depreciation and Amortization | 0.62% | 4.36% | 0.27% | 9.52% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -90.40% | -89.11% | 0.34% | 85.82% | |
| Change in Net Operating Assets | 230.69% | 87.94% | -188.62% | -184.54% | |
| Cash from Operations | 124.51% | 50.51% | -12.45% | -19.52% | |
| Capital Expenditure | -74.05% | -40.62% | -151.27% | -40.51% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 241.66% | -335.58% | -214.52% | -2,570.00% | |
| Cash from Investing | 221.98% | -604.56% | -209.66% | -1,907.75% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 315.94% | 48.57% | -41.57% | 85.68% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 315.94% | 48.57% | -41.57% | 85.68% | |
| Foreign Exchange rate Adjustments | 3,695.92% | -254.29% | -800.00% | -424.32% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 673.46% | 5.45% | -234.22% | -692.26% | |